SCHEMBL7040217

SCHEMBL7040217

Cc1ccncc1Nc1ccc(C(=O)c2ccccc2C)c(F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 11/20 0.55
MAPK12 P53778 11/20 0.55
MAPK11 Q15759 11/20 0.55
MAPK14 Q16539 11/20 0.55
GSK3B P49841 2/20 0.43
AURKA O14965 1/20 0.43
MAP4K4 O95819 1/20 0.43
PIM1 P11309 1/20 0.43
CDK2 P24941 1/20 0.43
MAPK8 P45983 1/20 0.43
AURKB Q96GD4 1/20 0.43
HIPK2 Q9H2X6 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
IRAK4 Q9NWZ3 1/20 0.43
IMPDH2 P12268 1/20 0.41
TYK2 P29597 1/20 0.41
DHODH Q02127 2/20 0.41
GSK3A P49840 1/20 0.39
GPBAR1 Q8TDU6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7036435 0.86 MAPK14 (0.41) MAPK13MAPK12MAPK11MAPK14GSK3B
SCHEMBL7034038 0.86 MAPK14 (0.76) MAPK13MAPK12MAPK11MAPK14IMPDH2
SCHEMBL7040515 0.84 MAPK14 (0.40) MAPK13MAPK12MAPK11MAPK14GSK3B
SCHEMBL7512487 0.83 MAPK13 (0.40) MAPK13MAPK12MAPK11MAPK14IMPDH2
SCHEMBL6812866 0.80 MAPK14 (0.81) MAPK13MAPK12MAPK11MAPK14
SCHEMBL5173305 0.78 MAPK13 (0.61) MAPK13MAPK12MAPK11MAPK14DHODH
SCHEMBL6820793 0.76 MAPK14 (0.57) MAPK13MAPK12MAPK11MAPK14GSK3B
SCHEMBL7192088 0.76 MAPK13 (0.76) MAPK13MAPK12MAPK11MAPK14
SCHEMBL7033698 0.75 MAPK14 (0.59) MAPK13MAPK12MAPK11MAPK14DHODH
SCHEMBL6396818 0.75 MAPK14 (0.77) MAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP claimed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US claimed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US claimed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO claimed
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP disclosed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US disclosed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US disclosed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha IL1B, IL1A, NFKBIA MAPK13 1908/4885MAPK12 1184/4885MAPK11 2116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.